TCRT icon

Alaunos Therapeutics

122 hedge funds and large institutions have $356M invested in Alaunos Therapeutics in 2017 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 34 increasing their positions, 31 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more funds holding in top 10

Funds holding in top 10:

0.01% less ownership

Funds ownership: 0.28%0.27% (-0.01%)

5% less capital invested

Capital invested by funds: $376M → $356M (-$19.8M)

47% less call options, than puts

Call options by funds: $4.96M | Put options by funds: $9.29M

Holders
122
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$4.96M
Puts
$9.29M
Net Calls
Net Calls Change

Top Buyers

1 +$2.81M
2 +$1.98M
3 +$872K
4
Goldman Sachs
Goldman Sachs
New York
+$823K
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$764K
Name Holding Trade Value Shares
Change
Change in
Stake
26
$1.19M
27
$1.15M
28
$1.08M
29
$1.01M
30
$982K
31
$967K
32
$939K
33
$880K
34
$847K
35
$775K
36
$749K
37
$746K
38
$685K
39
$630K
40
$614K
41
$541K
42
$525K
43
$490K
44
$437K
45
$412K
46
$410K
47
$406K
48
$391K
49
$383K
50
$373K